Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

C4 Therapeutics (CCCC) Tax Rate (2019 - 2024)

C4 Therapeutics' Tax Rate history spans 4 years, with the latest figure at 0.38% for Q4 2024.

  • For Q4 2024, Tax Rate rose 43.0% year-over-year to 0.38%; the TTM value through Dec 2024 reached 0.12%, up 85.0%, while the annual FY2025 figure was 0.12%, 1.0% up from the prior year.
  • Tax Rate reached 0.38% in Q4 2024 per CCCC's latest filing, up from 0.81% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 1.53% in Q2 2020 to a low of 3.85% in Q3 2023.
  • Average Tax Rate over 3 years is 0.12%, with a median of 0.57% recorded in 2020.
  • The largest YoY upside for Tax Rate was 764bps in 2020 against a maximum downside of -38bps in 2020.
  • A 3-year view of Tax Rate shows it stood at 0.57% in 2020, then crashed by -244bps to 0.81% in 2023, then skyrocketed by 53bps to 0.38% in 2024.
  • Per Business Quant, the three most recent readings for CCCC's Tax Rate are 0.38% (Q4 2024), 0.81% (Q4 2023), and 3.85% (Q3 2023).